176 related articles for article (PubMed ID: 22167416)
1. Characterization of oral disintegrating film containing donepezil for Alzheimer disease.
Liew KB; Tan YT; Peh KK
AAPS PharmSciTech; 2012 Mar; 13(1):134-42. PubMed ID: 22167416
[TBL] [Abstract][Full Text] [Related]
2. Effect of polymer, plasticizer and filler on orally disintegrating film.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
[TBL] [Abstract][Full Text] [Related]
3. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets.
Yan YD; Woo JS; Kang JH; Yong CS; Choi HG
Biol Pharm Bull; 2010; 33(8):1364-70. PubMed ID: 20686233
[TBL] [Abstract][Full Text] [Related]
5. Formulation and characterization of orodispersible film containing diltiazem hydrochloride with taste masked effects.
Latif S; Kokab A; Afzal H; Shoaib QA; Hameed M; Manzoor M; Batool N; Ijaz QA
Pak J Pharm Sci; 2022 Jul; 35(4):1007-1014. PubMed ID: 36008896
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
8. Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics.
Rofiq HM; Phang HC; Janakiraman AK; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):512-521. PubMed ID: 38100669
[TBL] [Abstract][Full Text] [Related]
9. Development of aprepitant loaded orally disintegrating films for enhanced pharmacokinetic performance.
Sharma R; Kamboj S; Singh G; Rana V
Eur J Pharm Sci; 2016 Mar; 84():55-69. PubMed ID: 26780381
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology.
Pimparade MB; Vo A; Maurya AS; Bae J; Morott JT; Feng X; Kim DW; Kulkarni VI; Tiwari R; Vanaja K; Murthy R; Shivakumar HN; Neupane D; Mishra SR; Murthy SN; Repka MA
Eur J Pharm Biopharm; 2017 Oct; 119():81-90. PubMed ID: 28596037
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of transdermal patches of donepezil.
Madan JR; Argade NS; Dua K
Recent Pat Drug Deliv Formul; 2015; 9(1):95-103. PubMed ID: 25354347
[TBL] [Abstract][Full Text] [Related]
12. An advanced technique using an electronic taste-sensing system to evaluate the bitterness of orally disintegrating films and the evaluation of model films.
Takeuchi Y; Usui R; Ikezaki H; Tahara K; Takeuchi H
Int J Pharm; 2017 Oct; 531(1):179-190. PubMed ID: 28789886
[TBL] [Abstract][Full Text] [Related]
13. Development of taste masked fast disintegrating films of levocetirizine dihydrochloride for oral use.
Mahesh A; Shastri N; Sadanandam M
Curr Drug Deliv; 2010 Jan; 7(1):21-7. PubMed ID: 19863484
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of oral fast disintegrating film of ranitidine HCl by solvent casting method.
Rashid A; Khan IU; Khalid SH; Asghar S; Munir MU
Pak J Pharm Sci; 2021 Jul; 34(4(Supplementary)):1527-1534. PubMed ID: 34799328
[TBL] [Abstract][Full Text] [Related]
15. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
Rogers SL; Doody RS; Mohs RC; Friedhoff LT
Arch Intern Med; 1998 May; 158(9):1021-31. PubMed ID: 9588436
[TBL] [Abstract][Full Text] [Related]
16. [Orally disintegrating donepezil: are the main caregivers of patients with Alzheimer's disease more satisfied with this formulation of donepezil than with the traditional one?].
Sevilla C; Jiménez-Caballero PE; Alfonso V
Rev Neurol; 2009 Nov 1-15; 49(9):451-7. PubMed ID: 19859884
[TBL] [Abstract][Full Text] [Related]
17. In vivo visualization of donepezil binding in the brain of patients with Alzheimer's disease.
Okamura N; Funaki Y; Tashiro M; Kato M; Ishikawa Y; Maruyama M; Ishikawa H; Meguro K; Iwata R; Yanai K
Br J Clin Pharmacol; 2008 Apr; 65(4):472-9. PubMed ID: 18070217
[TBL] [Abstract][Full Text] [Related]
18. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets.
Khan S; Kataria P; Nakhat P; Yeole P
AAPS PharmSciTech; 2007 Jun; 8(2):Article 46. PubMed ID: 17622121
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of an orodispersible film containing drug nanoparticles.
Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
[TBL] [Abstract][Full Text] [Related]
20. Formulation and Characterization of Fast-Dissolving Sublingual Film of Iloperidone Using Box-Behnken Design for Enhancement of Oral Bioavailability.
Londhe V; Shirsat R
AAPS PharmSciTech; 2018 Apr; 19(3):1392-1400. PubMed ID: 29396734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
